Pfizer Inc. news

   Watch this stock
Showing stories 11 - 20 of about 175   

Articles published

PFE 31.15 +0.05 (0.16%)
price chart
3 Dividend Stocks Better Than Pfizer, Inc.
Pfizer (NYSE: PFE ) reported third-quarter earnings this week that were generally underwhelming. The drugmaker announced that its sales sagged 2.2% to $12.36 billion and its adjusted EPS fell similarly by 2% year over year in the quarter.
Related articles »  
Op-Ed: Pfizer Inc. is active, vital, taxpaying part of Eastern Connecticut
The Chamber of Commerce of Eastern Connecticut would like to set the record straight regarding Pfizer Inc.'s presence and future in southeastern Connecticut.
Related articles »  
TAMC, Healthy Aroostook and Pfizer launch Beat-the-Pack smoking cessation ...
Looking to clear the air and create a more healthy community by providing County smokers a new tool to quit, The Aroostook Medical Center and Aroostook County Action Program's Healthy Aroostook, with the help of Pfizer Inc., took advantage of a day set ...
Related articles »  
Is Pfizer Spending Enough On R&D?
The company also stated in the 10-K that R&D spending may include upfront and milestone payments for intellectual property rights.
Related articles »  
One Put, One Call Option To Know About for Pfizer
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer PFE +0.23% Inc (NYSE: PFE). So this week we highlight one interesting put contract, and one interesting call contract, from ...
Related articles »  
Report: Pfizer 'Unlikely' To Pursue Acquisition Of AstraZeneca
A separate banker who is also familiar with Pfizer's strategy told Reuters that the company ´┐Żnever stopped looking at targets in Europe after the AstraZeneca debacle.
Related articles »  
AstraZeneca Is Building Value Without Pfizer, CEO Says
AstraZeneca Plc (AZN)'s stock has climbed to the price that Pfizer Inc. (PFE) initially offered to buy the U.K. drugmaker, indicating the company can create value without a buyout, Chief Executive Officer Pascal Soriot said.
AstraZeneca CEO Hints Another Bid From Pfizer Is Unlikely  Bidness ETC
AstraZeneca Profit Outlook Improves on Rising Sales  Wall Street Journal
Related articles »  
Interesting January 2015 Stock Options for Pfizer
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer PFE +2.07% Inc (NYSE: PFE). So this week we highlight one interesting put contract, and one interesting call contract, from ...
Related articles »  
Wall Street's Beloved Stocks: Facebook Inc (NASDAQ:FB), Pfizer Inc. (NYSE ...
Facebook Inc (NASDAQ:FB) extended gains amid renewed rumors that the tech giant is developing a site will allow users to chat with colleagues, recruit with other professionals and collaborate over work-related documents.
Actavis plc (ACT), Allergan, Inc. (AGN), Pfizer Inc. (PFE): Hedge Funds ...
Pfizer Inc. (NYSE:PFE) is next on the list, with 91 funds reporting long positions, versus 87 in the previous quarter. However, the aggregate value of the positions held by these funds declined to $5.02 billion, from $5.38 billion.
Related articles »